Published in Schizophr Res on January 31, 2009
A small recurrent deletion within 15q13.3 is associated with a range of neurodevelopmental phenotypes. Nat Genet (2009) 1.98
Analysis of 94 candidate genes and 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia. Am J Psychiatry (2011) 1.93
Effects of an alpha 7-nicotinic agonist on default network activity in schizophrenia. Biol Psychiatry (2010) 1.45
Synaptic proteins in the hippocampus indicative of increased neuronal activity in CA3 in schizophrenia. Am J Psychiatry (2015) 1.40
The interstitial duplication 15q11.2-q13 syndrome includes autism, mild facial anomalies and a characteristic EEG signature. Autism Res (2013) 1.36
The astrocyte-derived alpha7 nicotinic receptor antagonist kynurenic acid controls extracellular glutamate levels in the prefrontal cortex. J Mol Neurosci (2009) 1.28
A 2-base pair deletion polymorphism in the partial duplication of the alpha7 nicotinic acetylcholine gene (CHRFAM7A) on chromosome 15q14 is associated with schizophrenia. Brain Res (2009) 1.13
The chimeric gene CHRFAM7A, a partial duplication of the CHRNA7 gene, is a dominant negative regulator of α7*nAChR function. Biochem Pharmacol (2011) 1.06
Two complex genotypes relevant to the kynurenine pathway and melanotropin function show association with schizophrenia and bipolar disorder. Schizophr Res (2009) 1.05
Alpha7 nicotinic acetylcholine receptors modulate motivation to self-administer nicotine: implications for smoking and schizophrenia. Neuropsychopharmacology (2011) 1.01
A CHRNA5 allele related to nicotine addiction and schizophrenia. Genes Brain Behav (2011) 0.92
Prioritization of epilepsy associated candidate genes by convergent analysis. PLoS One (2011) 0.92
The human CHRNA7 and CHRFAM7A genes: A review of the genetics, regulation, and function. Neuropharmacology (2015) 0.90
Multiple genes in the 15q13-q14 chromosomal region are associated with schizophrenia. Psychiatr Genet (2012) 0.89
Assessment of α7 nicotinic acetylcholine receptor availability in juvenile pig brain with [¹⁸F]NS10743. Eur J Nucl Med Mol Imaging (2011) 0.89
The duplicated α7 subunits assemble and form functional nicotinic receptors with the full-length α7. J Biol Chem (2014) 0.88
The α7 nicotinic acetylcholine receptor and the acute stress response: maternal genotype determines offspring phenotype. Physiol Behav (2010) 0.85
Nicotinic modulation of intrinsic brain networks in schizophrenia. Biochem Pharmacol (2013) 0.83
Personalized medicine and tobacco-related health disparities: is there a role for genetics? Ann Fam Med (2011) 0.80
Association of the Nicotinic Receptor α7 Subunit Gene (CHRNA7) with Schizophrenia and Visual Backward Masking. Front Psychiatry (2013) 0.80
Clinical utility gene card for: 15q13.3 microdeletion syndrome. Eur J Hum Genet (2014) 0.80
Genetic Relationship between Schizophrenia and Nicotine Dependence. Sci Rep (2016) 0.80
Effect of alpha7 nicotinic acetylcholine receptor agonists on attentional set-shifting impairment in rats. Psychopharmacology (Berl) (2013) 0.78
Transcriptional repression of the α7 nicotinic acetylcholine receptor subunit gene (CHRNA7) by activating protein-2α (AP-2α). J Biol Chem (2011) 0.78
α7 and β2 Nicotinic Acetylcholine Receptor Subunits Form Heteromeric Receptor Complexes that Are Expressed in the Human Cortex and Display Distinct Pharmacological Properties. PLoS One (2015) 0.78
Prenatal choline and the development of schizophrenia. Shanghai Arch Psychiatry (2015) 0.78
Evidence for gamma and beta sensory gating deficits as translational endophenotypes for schizophrenia. Psychiatry Res (2013) 0.77
Novel population specific autosomal copy number variation and its functional analysis amongst Negritos from Peninsular Malaysia. PLoS One (2014) 0.77
Targeting Functional Biomarkers in Schizophrenia with Neuroimaging. Curr Pharm Des (2016) 0.77
Endophenotypes in Schizophrenia for the Perinatal Period: Criteria for Validation. Schizophr Bull (2015) 0.77
Reduced CHRNA7 expression in C3H mice is associated with increases in hippocampal parvalbumin and glutamate decarboxylase-67 (GAD67) as well as altered levels of GABA(A) receptor subunits. Neuroscience (2014) 0.76
Multivariate Genetic Correlates of the Auditory Paired Stimuli-Based P2 Event-Related Potential in the Psychosis Dimension From the BSNIP Study. Schizophr Bull (2015) 0.75
15q13.3 duplication in two patients with childhood-onset schizophrenia. Am J Med Genet B Neuropsychiatr Genet (2016) 0.75
Genomewide association analyses of electrophysiological endophenotypes for schizophrenia and psychotic bipolar disorders: a preliminary report. Am J Med Genet B Neuropsychiatr Genet (2015) 0.75
Chrna7 deficient mice manifest no consistent neuropsychiatric and behavioral phenotypes. Sci Rep (2017) 0.75
Inference of population structure using multilocus genotype data. Genetics (2000) 147.76
Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics (2004) 125.23
A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res (1988) 77.80
The structure of haplotype blocks in the human genome. Science (2002) 50.88
Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry (1997) 41.93
Use of unlinked genetic markers to detect population stratification in association studies. Am J Hum Genet (1999) 23.67
PedCheck: a program for identification of genotype incompatibilities in linkage analysis. Am J Hum Genet (1998) 23.25
alpha-Synuclein locus triplication causes Parkinson's disease. Science (2003) 20.20
Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry (2005) 9.23
Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol (2003) 8.65
Schizophrenia: a common disease caused by multiple rare alleles. Br J Psychiatry (2007) 7.00
Sample size requirements for association studies of gene-gene interaction. Am J Epidemiol (2002) 6.09
Sample size requirements for matched case-control studies of gene-environment interaction. Stat Med (2002) 5.00
Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc Natl Acad Sci U S A (1997) 4.89
No gene is an island: the flip-flop phenomenon. Am J Hum Genet (2007) 4.69
Brain nicotinic acetylcholine receptors: native subtypes and their relevance. Trends Pharmacol Sci (2006) 4.04
Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization. Psychopharmacology (Berl) (2005) 3.92
Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones. Cancer Res (1978) 3.51
Initial phase 2 trial of a nicotinic agonist in schizophrenia. Am J Psychiatry (2008) 3.13
Addictions biology: haplotype-based analysis for 130 candidate genes on a single array. Alcohol Alcohol (2008) 3.13
Association between a functional catechol O-methyltransferase gene polymorphism and schizophrenia: meta-analysis of case-control and family-based studies. Am J Psychiatry (2003) 3.12
Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia. Biol Psychiatry (1995) 2.72
Proof-of-concept trial of an alpha7 nicotinic agonist in schizophrenia. Arch Gen Psychiatry (2006) 2.63
Evidence for linkage disequilibrium between the alpha 7-nicotinic receptor gene (CHRNA7) locus and schizophrenia in Azorean families. Am J Med Genet (2001) 2.48
Association of promoter variants in the alpha7 nicotinic acetylcholine receptor subunit gene with an inhibitory deficit found in schizophrenia. Arch Gen Psychiatry (2002) 2.47
Cognitive effects of nicotine. Biol Psychiatry (2001) 2.41
Nicotinic acetylcholine receptors and the regulation of neuronal signalling. Trends Pharmacol Sci (2004) 2.33
Alpha-7 nicotinic receptor agonists: potential new candidates for the treatment of schizophrenia. Psychopharmacology (Berl) (2004) 2.19
Normalization of auditory physiology by cigarette smoking in schizophrenic patients. Am J Psychiatry (1993) 2.17
NIMH Genetics Initiative Millenium Schizophrenia Consortium: linkage analysis of African-American pedigrees. Am J Med Genet (1998) 2.09
Effect of smoking history on [3H]nicotine binding in human postmortem brain. J Pharmacol Exp Ther (1997) 1.98
Nicotine use in schizophrenia: the self medication hypotheses. Neurosci Biobehav Rev (2005) 1.93
Schizophrenia, sensory gating, and nicotinic receptors. Schizophr Bull (1998) 1.92
Genomic scan for genes predisposing to schizophrenia. Am J Med Genet (1994) 1.86
Abnormal regulation of high affinity nicotinic receptors in subjects with schizophrenia. Neuropsychopharmacology (2000) 1.77
Schizophrenia and the alpha7 nicotinic acetylcholine receptor. Int Rev Neurobiol (2007) 1.65
Smoking and mental illness. Pharmacol Biochem Behav (2001) 1.63
Transdermal nicotine effects on attention. Psychopharmacology (Berl) (1998) 1.61
Linkage disequilibrium for schizophrenia at the chromosome 15q13-14 locus of the alpha7-nicotinic acetylcholine receptor subunit gene (CHRNA7). Am J Med Genet (2001) 1.47
Genomewide linkage scan for schizophrenia susceptibility loci among Ashkenazi Jewish families shows evidence of linkage on chromosome 10q22. Am J Hum Genet (2003) 1.40
Decreased protein level of nicotinic receptor alpha7 subunit in the frontal cortex from schizophrenic brain. Neuroreport (1999) 1.38
Genomic organization and partial duplication of the human alpha7 neuronal nicotinic acetylcholine receptor gene (CHRNA7). Genomics (1998) 1.36
Nicotinic receptors that bind alpha-bungarotoxin on neurons raise intracellular free Ca2+. Neuron (1992) 1.34
Nicotinic alpha 7 receptors: synaptic options and downstream signaling in neurons. J Neurobiol (2002) 1.34
Neuronal nicotinic receptors in dementia with Lewy bodies and schizophrenia: alpha-bungarotoxin and nicotine binding in the thalamus. J Neurochem (1999) 1.33
A 3-Mb map of a large Segmental duplication overlapping the alpha7-nicotinic acetylcholine receptor gene (CHRNA7) at human 15q13-q14. Genomics (2002) 1.31
Elementary neuronal dysfunctions in schizophrenia. Schizophr Res (1991) 1.27
Laminar distribution of nicotinic receptor subtypes in cortical regions in schizophrenia. J Chem Neuroanat (2001) 1.20
Association between Val108/158 Met polymorphism of the COMT gene and schizophrenia. Am J Med Genet B Neuropsychiatr Genet (2003) 1.18
Comparison of polymorphisms in the alpha7 nicotinic receptor gene and its partial duplication in schizophrenic and control subjects. Am J Med Genet B Neuropsychiatr Genet (2003) 1.17
Neuronal nicotinic receptors: from structure to function. Nicotine Tob Res (2001) 1.17
Haplotypic association spanning the 22q11.21 genes COMT and ARVCF with schizophrenia. Mol Psychiatry (2005) 1.17
Differential modulation of gene expression in the NMDA postsynaptic density of schizophrenic and control smokers. Brain Res Mol Brain Res (2005) 1.17
A preliminary study of the effects of cigarette smoking on prepulse inhibition in schizophrenia: involvement of nicotinic receptor mechanisms. Schizophr Res (2006) 1.16
Nicotine selectively enhances NMDA receptor-mediated synaptic transmission during postnatal development in sensory neocortex. J Neurosci (1998) 1.13
Haplotype transmission disequilibrium and evidence for linkage of the CHRNA7 gene region to schizophrenia in Southern African Bantu families. Am J Med Genet (2000) 1.11
Linkage analysis of schizophrenia to chromosome 15. Am J Med Genet (2001) 1.10
Case-control study and transmission disequilibrium test provide consistent evidence for association between schizophrenia and genetic variation in the 22q11 gene ZDHHC8. Hum Mol Genet (2004) 1.08
Examination of genetic linkage of chromosome 15 to schizophrenia in a large Veterans Affairs Cooperative Study sample. Am J Med Genet (2001) 1.07
Further investigation of a chromosome 15 locus in schizophrenia: analysis of affected sibpairs from the NIMH Genetics Initiative. Am J Med Genet (1998) 1.07
Smoking, Genetics and Schizophrenia: Evidence for Self Medication. J Dual Diagn (2007) 1.04
Suggestive evidence for linkage of schizophrenia to markers at chromosome 15q13-14 in Taiwanese families. Am J Med Genet (2001) 1.02
Alpha synuclein promoter and risk of Parkinson's disease: microsatellite and allelic size variability. Neurosci Lett (2003) 1.00
Improvement in smooth pursuit eye movements after cigarette smoking in schizophrenic patients. Neuropsychopharmacology (1998) 0.99
Functional catechol-O-methyltransferase gene polymorphism and susceptibility to schizophrenia. Eur Neuropsychopharmacol (2002) 0.99
Evidence for a role of nicotinic acetylcholine receptors in schizophrenia. Front Biosci (2007) 0.96
Regulation of a novel alphaN-catenin splice variant in schizophrenic smokers. Am J Med Genet B Neuropsychiatr Genet (2008) 0.94
Genetic linkage to schizophrenia at chromosome 15q14. Am J Med Genet (2001) 0.93
Link between smoking and mental illness may lead to treatments. JAMA (2006) 0.82
Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat Genet (2008) 10.52
Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature (2009) 8.12
Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet (2013) 8.02
A common MUC5B promoter polymorphism and pulmonary fibrosis. N Engl J Med (2011) 6.40
Truncations of titin causing dilated cardiomyopathy. N Engl J Med (2012) 6.07
Copy number variants in schizophrenia: confirmation of five previous findings and new evidence for 3q29 microdeletions and VIPR2 duplications. Am J Psychiatry (2011) 4.29
No significant association of 14 candidate genes with schizophrenia in a large European ancestry sample: implications for psychiatric genetics. Am J Psychiatry (2008) 3.23
Initial heritability analyses of endophenotypic measures for schizophrenia: the consortium on the genetics of schizophrenia. Arch Gen Psychiatry (2007) 2.91
Genetic and environmental determinants of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels in Hispanic and African Americans. J Clin Endocrinol Metab (2008) 2.87
Proof-of-concept trial of an alpha7 nicotinic agonist in schizophrenia. Arch Gen Psychiatry (2006) 2.63
Association of promoter variants in the alpha7 nicotinic acetylcholine receptor subunit gene with an inhibitory deficit found in schizophrenia. Arch Gen Psychiatry (2002) 2.47
A large set of Finnish affected sibling pair families with type 2 diabetes suggests susceptibility loci on chromosomes 6, 11, and 14. Diabetes (2004) 2.46
Deconstructing schizophrenia: an overview of the use of endophenotypes in order to understand a complex disorder. Schizophr Bull (2006) 2.46
Genetic variation near the hepatocyte nuclear factor-4 alpha gene predicts susceptibility to type 2 diabetes. Diabetes (2004) 2.43
The initial field trials of DSM-5: new blooms and old thorns. Am J Psychiatry (2013) 2.39
High-throughput screening for evidence of association by using mass spectrometry genotyping on DNA pools. Proc Natl Acad Sci U S A (2002) 2.32
MUC5B promoter polymorphism and interstitial lung abnormalities. N Engl J Med (2013) 2.31
Conflict of interest. Am J Psychiatry (2006) 2.30
Exacerbation of schizophrenia by varenicline. Am J Psychiatry (2007) 2.27
Intrinsic hippocampal activity as a biomarker for cognition and symptoms in schizophrenia. Am J Psychiatry (2014) 2.21
Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosis. JAMA (2013) 2.20
Alpha-7 nicotinic receptor agonists: potential new candidates for the treatment of schizophrenia. Psychopharmacology (Berl) (2004) 2.19
The Internet-based MGS2 control sample: self report of mental illness. Am J Psychiatry (2010) 2.05
Using ancestry-informative markers to define populations and detect population stratification. J Psychopharmacol (2006) 1.98
Analysis of 94 candidate genes and 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia. Am J Psychiatry (2011) 1.93
Rapid induction of therapeutic hypothermia using convective-immersion surface cooling: safety, efficacy and outcomes. Resuscitation (2010) 1.93
Genomewide linkage scan of 409 European-ancestry and African American families with schizophrenia: suggestive evidence of linkage at 8p23.3-p21.2 and 11p13.1-q14.1 in the combined sample. Am J Hum Genet (2006) 1.89
The Consortium on the Genetics of Endophenotypes in Schizophrenia: model recruitment, assessment, and endophenotyping methods for a multisite collaboration. Schizophr Bull (2006) 1.88
Analysis of single nucleotide polymorphisms identifies major type 1A diabetes locus telomeric of the major histocompatibility complex. Diabetes (2007) 1.84
Neural systems governed by nicotinic acetylcholine receptors: emerging hypotheses. Neuron (2011) 1.82
Genetical genomic determinants of alcohol consumption in rats and humans. BMC Biol (2009) 1.81
Expression of cilium-associated genes defines novel molecular subtypes of idiopathic pulmonary fibrosis. Thorax (2013) 1.77
Altered glutathione redox state in schizophrenia. Dis Markers (2006) 1.67
Schizophrenia and the alpha7 nicotinic acetylcholine receptor. Int Rev Neurobiol (2007) 1.65
Association of 25-hydroxyvitamin D with blood pressure in predominantly 25-hydroxyvitamin D deficient Hispanic and African Americans. Am J Hypertens (2009) 1.60
Genetic variation in titin in arrhythmogenic right ventricular cardiomyopathy-overlap syndromes. Circulation (2011) 1.51
Varied effects of atypical neuroleptics on P50 auditory gating in schizophrenia patients. Am J Psychiatry (2004) 1.49
Hair cortisol levels as a retrospective marker of hypothalamic-pituitary axis activity throughout pregnancy: comparison to salivary cortisol. Physiol Behav (2011) 1.49
Effects of an alpha 7-nicotinic agonist on default network activity in schizophrenia. Biol Psychiatry (2010) 1.45
Conflict of interest, round 2. Am J Psychiatry (2006) 1.44
Neuronal dysfunction and schizophrenia symptoms. Am J Psychiatry (2007) 1.42
Increased hemodynamic response in the hippocampus, thalamus and prefrontal cortex during abnormal sensory gating in schizophrenia. Schizophr Res (2007) 1.42
Psychotherapy in the Journal: what's missing? Am J Psychiatry (2006) 1.38
Challenges and opportunities in genome-wide environmental interaction (GWEI) studies. Hum Genet (2012) 1.37
Effects of nicotine on cognitive deficits in schizophrenia. Neuropsychopharmacology (2004) 1.37
Genetics of chromosome 15q13-q14 in schizophrenia. Biol Psychiatry (2006) 1.36
Perinatal choline effects on neonatal pathophysiology related to later schizophrenia risk. Am J Psychiatry (2013) 1.34
Genome-wide linkage analyses of 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia. Am J Psychiatry (2013) 1.30
Verbal working memory impairments in individuals with schizophrenia and their first-degree relatives: findings from the Consortium on the Genetics of Schizophrenia. Schizophr Res (2008) 1.29
The genetics of sensory gating deficits in schizophrenia. Curr Psychiatry Rep (2003) 1.26
Successful multi-site measurement of antisaccade performance deficits in schizophrenia. Schizophr Res (2006) 1.25
Neurobiology of smooth pursuit eye movement deficits in schizophrenia: an fMRI study. Am J Psychiatry (2004) 1.25
Genome-wide association study implicates NDST3 in schizophrenia and bipolar disorder. Nat Commun (2013) 1.25
Heritability and reliability of P300, P50 and duration mismatch negativity. Behav Genet (2006) 1.22
Development of the alpha7 nicotinic cholinergic receptor in rat hippocampal formation. Brain Res Dev Brain Res (2002) 1.21
Recent advances in the development of novel pharmacological agents for the treatment of cognitive impairments in schizophrenia. Schizophr Bull (2007) 1.21
Amygdala function and 5-HTT gene variants in adolescent anxiety and major depressive disorder. Biol Psychiatry (2008) 1.20
Abnormal auditory N100 amplitude: a heritable endophenotype in first-degree relatives of schizophrenia probands. Biol Psychiatry (2008) 1.19
Comparison of polymorphisms in the alpha7 nicotinic receptor gene and its partial duplication in schizophrenic and control subjects. Am J Med Genet B Neuropsychiatr Genet (2003) 1.17
Clozapine improves deficient inhibitory auditory processing in DBA/2 mice, via a nicotinic cholinergic mechanism. Psychopharmacology (Berl) (2002) 1.17
Genome-wide association study of clinical dimensions of schizophrenia: polygenic effect on disorganized symptoms. Am J Psychiatry (2012) 1.15
Clinically responsible genetic testing in neuropsychiatric patients: a bridge too far and too soon. Am J Psychiatry (2008) 1.15
Rare variants in RTEL1 are associated with familial interstitial pneumonia. Am J Respir Crit Care Med (2015) 1.15
Association of the calpain-10 gene with type 2 diabetes in Europeans: results of pooled and meta-analyses. Mol Genet Metab (2006) 1.14
Evidence of interaction between PPARG2 and HNF4A contributing to variation in insulin sensitivity in Mexican Americans. Diabetes (2007) 1.14
BDNF gene polymorphism (Val66Met) predicts amygdala and anterior hippocampus responses to emotional faces in anxious and depressed adolescents. Neuroimage (2009) 1.14
Comparison of detrending methods for optimal fMRI preprocessing. Neuroimage (2002) 1.14
A 2-base pair deletion polymorphism in the partial duplication of the alpha7 nicotinic acetylcholine gene (CHRFAM7A) on chromosome 15q14 is associated with schizophrenia. Brain Res (2009) 1.13
Antidepressants may mitigate the effects of prenatal maternal anxiety on infant auditory sensory gating. Am J Psychiatry (2012) 1.12
Multi-site studies of acoustic startle and prepulse inhibition in humans: initial experience and methodological considerations based on studies by the Consortium on the Genetics of Schizophrenia. Schizophr Res (2007) 1.11
Increased nitric oxide radicals in postmortem brain from patients with schizophrenia. Schizophr Bull (2004) 1.11
The pulmonary fibrosis-associated MUC5B promoter polymorphism does not influence the development of interstitial pneumonia in systemic sclerosis. Chest (2012) 1.10
Maternal stress during pregnancy causes sex-specific alterations in offspring memory performance, social interactions, indices of anxiety, and body mass. Physiol Behav (2011) 1.09
Reduced heart rate variability among youth with type 1 diabetes: the SEARCH CVD study. Diabetes Care (2012) 1.08
Interleukin-18 knockout mice display maladaptive cardiac hypertrophy in response to pressure overload. Biochem Biophys Res Commun (2007) 1.07
Research review: Cholinergic mechanisms, early brain development, and risk for schizophrenia. J Child Psychol Psychiatry (2009) 1.06
The chimeric gene CHRFAM7A, a partial duplication of the CHRNA7 gene, is a dominant negative regulator of α7*nAChR function. Biochem Pharmacol (2011) 1.06
Effects of interval duration on temporal processing in schizophrenia. Brain Cogn (2003) 1.06
P50 sensory gating in adolescents from a pacific island isolate with elevated risk for schizophrenia. Biol Psychiatry (2004) 1.05
Two complex genotypes relevant to the kynurenine pathway and melanotropin function show association with schizophrenia and bipolar disorder. Schizophr Res (2009) 1.05